These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37169934)

  • 1. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Mukund A; Marri UK; Jindal A; Choudhury A; Patidar Y; Sarin SK
    Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W; Zhang H; Zeng Z; Wang X; Kong D
    Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
    Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
    Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis.
    Klinger C; Riecken B; Schmidt A; De Gottardi A; Meier B; Bosch J; Caca K
    Z Gastroenterol; 2018 Mar; 56(3):221-237. PubMed ID: 29113006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access.
    Mansour N; Öcal O; Gerwing M; Köhler M; Deniz S; Heinzow H; Steib C; Angele MK; Seidensticker M; Ricke J; Wildgruber M
    Abdom Radiol (NY); 2022 Mar; 47(3):1177-1186. PubMed ID: 35020007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunt and Thrombectomy (TIPS-Thrombectomy) for Symptomatic Acute Noncirrhotic Portal Vein Thrombosis.
    Shalvoy MR; Ahmed M; Weinstein JL; Ramalingam V; Malik MS; Ali A; Shenoy-Bhangle AS; Curry MP; Sarwar A
    J Vasc Interv Radiol; 2023 Aug; 34(8):1373-1381.e3. PubMed ID: 37182668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
    Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis.
    Klinger C; Riecken B; Schmidt A; De Gottardi A; Meier B; Bosch J; Caca K
    Dig Liver Dis; 2017 Dec; 49(12):1345-1352. PubMed ID: 28733177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
    Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.
    Thornburg B; Desai K; Hickey R; Kulik L; Ganger D; Baker T; Abecassis M; Lewandowski RJ; Salem R
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):52-60. PubMed ID: 26997089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantation.
    Talwar A; Varghese J; Knight GM; Katariya N; Caicedo JC; Dietch Z; Borja-Cacho D; Ladner D; Christopher D; Baker T; Abecassis M; Mouli S; Desai K; Riaz A; Thornburg B; Salem R
    Hepatol Commun; 2022 Jul; 6(7):1803-1812. PubMed ID: 35220693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding.
    Tie J; Gou X; He C; Li K; Yuan X; Jia W; Niu J; Han N; Xu J; Zhu Y; Wang W
    Hepatol Int; 2023 Aug; 17(4):979-988. PubMed ID: 37097537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study.
    Zhang L; Huan H; Tong H; Wei B; Wang Z; Liu C; Wu H
    Medicine (Baltimore); 2020 Jan; 99(2):e18737. PubMed ID: 31914090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.